Kumyang Co., Ltd. (KRX:001570)
South Korea
· Delayed Price · Currency is KRW 9,900.00
-480.00 (-4.62%)
Mar 21, 2025, 4:50 PM KST
Kumyang Revenue
Kumyang had revenue of 22.63B KRW in the quarter ending September 30, 2025, a decrease of -43.94%. This brings the company's revenue in the last twelve months to 118.29B, down -24.41% year-over-year. In the year 2024, Kumyang had annual revenue of 153.73B with 1.12% growth.
Revenue (ttm)
118.29B
Revenue Growth
-24.41%
P/S Ratio
5.16
Revenue / Employee
308.85M
Employees
383
Market Cap
610.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 153.73B | 1.70B | 1.12% |
| Dec 31, 2023 | 152.03B | -50.81B | -25.05% |
| Dec 31, 2022 | 202.84B | -14.75B | -6.78% |
| Dec 31, 2021 | 217.58B | 41.41B | 23.51% |
| Dec 31, 2020 | 176.17B | 3.45B | 2.00% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Miwon Specialty Chemical | 532.41B |
| Miwon Commercial | 447.18B |
| TKG Huchems | 1,163.14B |
| UNID Company | 1,267.93B |
| Korea Petrochemical Ind. | 3,347.82B |
| Foosung | 462.73B |
| Kolon Life Science | 211.13B |
| ENF Technology | 652.75B |